PaxMedica, Inc. [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Sep-30-21	Jun-30-21	Jun-30-20
	10-Q	10-Q	S-1	10-Q	10-Q	S-1	10-Q	S-1/A
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	2.8	3.8	2.4	0.8	0.9	1.3	1.1	1,452.8
General and administrative	2.8	3.8	2.4	0.8	0.9	1.3	1.1	1,452.8
Research and development	0.6	0.2	0.3	0.2	1.1	0.4	0.9	74.1
Other operating expenses	0.1	-0.3		0.1
EBIT [+]	-3.5	-3.7	-2.7	-1.0	-2.0	-1.7	-2.0	-1,526.9
EBIT growth	237.6%	84.6%	57.2%	-47.8%			-99.9%	1007.3%
Non-recurring items [+]	-0.1	0.3		-0.1
Unusual expense	-0.1	0.3		-0.1
Interest expense	0.0	0.0	0.0
Interest expense	0.0	0.0	0.0
Other income (expense), net [+]	-0.1	0.2	-8.8	0.9	3.9	-1.4	-4.2
Gain (loss) on debt retirement		0.0	0.0
Change in fair value of warrants				0.0	2.2
Other non-ooperating expenses							0.0
Other	0.0	-0.1					0.0
Pre-tax income	-3.5	-3.8	-11.5	0.0	1.9	-3.1	-6.1	-1,526.9
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Earnings from continuing ops	-3.5	-3.8	-11.5	0.0	1.9	-3.1	-6.1	-1,526.9
Earnings from discontinued ops		-3.8
Net income	-3.5	-3.8	-11.5	0.0	1.9	-3.1	-6.1	-1,526.9

Basic EPS [+]	($0.24)	($0.30)	($1.25)	$0.00	$0.27	($0.45)	($0.89)
Growth	-8733.0%	-212.5%	177.6%	-100.3%
Diluted EPS [+]	($0.24)	($0.30)	($1.25)	$0.00	$0.25	($0.45)	($0.89)
Growth	-8733.0%	-223.1%	177.6%	-100.3%

Shares outstanding (basic) [+]	14.7	12.6	9.2	6.9	6.9	6.9	6.9
Growth	112.2%	82.8%	32.8%	0.0%
Shares outstanding (diluted) [+]	14.7	12.6	9.2	6.9	7.6	6.9	6.9
Growth	112.2%	67.1%	32.8%	0.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.